Survival and patient-reported outcomes of real-world high-risk stage II and stage III colon cancer patients after reduction of adjuvant CAPOX duration from 6 to 3 months

Autor: Franken, Ingrid A., van der Baan, Frederieke H., Vink, Geraldine R., May, Anne M., van Grevenstein, Wilhelmina M.U., Koopman, Miriam, Roodhart, Jeanine M.L.
Zdroj: In European Journal of Cancer September 2024 208
Databáze: ScienceDirect
Externí odkaz: